Figure 1.
Kaplan‐Meier curve for estimated progression‐free survival in MALT lymphoma patients treated with lenalidomide‐based therapy (n = 50). Legend. X‐axis follow‐up in months; y‐axis cumulative progression‐free survival
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.